arsenic trioxide medac
medac gesellschaft für klinische spezialpräparate mbh - arseenitrioksidi - leukemia, promyelocytic, akuutti - antineoplastiset aineet - arsenic trioxide medac is indicated for induction of remission, and consolidation in adult patients with:newly diagnosed low-to-intermediate risk acute promyelocytic leukaemia (apl) (white blood cell count, ≤ 10 x 10³/μl) in combination with all-trans-retinoic acid (atra)relapsed/refractory apl (previous treatment should have included a retinoid and chemotherapy) characterised by the presence of the t(15;17) translocation and/or the presence of the pro-myelocytic leukaemia/retinoic-acid-receptor-alpha (pml/rarα) gene. vastausprosentti muita akuutin myelooisen leukemian alatyyppien mukaan arseenitrioksidi ei ole tutkittu.
ayvakyt
blueprint medicines (netherlands) b.v. - avapritinib - ruoansulatuskanavan stromal-kasvaimet - muut antineoplastiset aineet, proteiinikinaasin estäjät - ayvakyt is indicated as monotherapy for the treatment of adult patients with unresectable or metastatic gastrointestinal stromal tumours (gist) harbouring the platelet-derived growth factor receptor alpha (pdgfra) d842v mutation.
banjo forte
adama - dimetomorf 200 g/l + fluazinam 200 g/l - kasvitautien torjunta
cloud
adama - kvinmerakki / kvinmerak 125 g/l + metatsaklori / metazaklor 375 g/l - rikkakasvien torjunta
mixin
adama - florasulaami 2,5 g/l + fluroksipyyri-i-metyyliheptyyliesteri 144 g/l - rikkakasvien torjunta